Population Health Perspectives is a recurring content series published on MHE and Formulary Watch through print, digital and video avenues. The series focuses on updates around new real-world evidence/data and trends that stand to impact treatment guidelines, access decisions, and patient experience.

Targeting the Clinical, Economic and Payer Considerations of Atopic Dermatitis

November 19th 2021

A payer and community physician raise attention to limitations surrounding measures for screening and treating atopic dermatitis.

Wet Age-Related Macular Degeneration: Understanding Disease Impact and Refining Treatment Approaches

July 1st 2021

A discussion on the clinical and managed care considerations of wet AMD treatment, including the varying approaches to disease management.

Secondary Progressive Multiple Sclerosis: Patient Impact and Coverage Implications for New Therapies

March 30th 2021

Examining Health Equity Among Different Racial and Ethnic Subpopulations With Multiple Sclerosis

March 26th 2021

Multiple sclerosis (MS) is a chronic disease that involves demyelination of plaque throughout the white and gray matter of the central nervous system. The early stages of MS are usually marked by a relapsing-remitting course of neurological deficits, which progress toward continuous, permanent dysfunction and disability. Of those with a diagnosis of MS, 74% are women.

Prescription Digital Therapeutics in Behavior-Driven Conditions

March 23rd 2021

A multi-stakeholder panel discussion featuring insight on the use of prescription digital therapeutics as tools when managing behavior-driven conditions.

Improving Ophthalmic Care Access and Treatment Among Aging Adults

March 22nd 2021

As the American population ages, chronic conditions are becoming an increasing challenge for payers. In addition to conditions such as cardiovascular disease and diabetes, eye disease is also prevalent among aging adults.